MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1468-3083.2011.04230.x

Медицинская библиотека · Journal of the European Academy of Dermatology and Venereology : JEADV · 2011

Risk of Herpes zoster in patients with psoriasis treated with biologic drugs.

Dreiher J, Kresch F S, Comaneshter D, Cohen A D

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Little is known about the risk of herpes zoster (HZ), among patients with psoriasis treated with biologic drugs.

OBJECTIVE

To determine the incidence of HZ in patients with psoriasis and the association between HZ and use of biologic drugs in these patients.

METHODS

The study was performed utilizing the medical database of Clalit Health Services in Israel. The incidence of HZ events was calculated among patients with psoriasis treated with phototherapy, traditional systemic medications and biologic drugs. Incidence rates of HZ events were calculated for each medication, as well as hazard ratios adjusted for age, sex and healthcare utilization burden.

RESULTS

Among 22,330 psoriasis patients (215,656 person-years), 1321 HZ cases were diagnosed. The crude incidence rates per 1000 person-years were 6.0 for UVB phototherapy (95% confidence interval (CI), 0-12.8), 10.1 for PUVΑ (1.3-19.0), 5.4 for acitretin (2.2-8.7), 17.0 for methotrexate (10.6-23.4), 13.9 for etanercept (0.3-27.4), 19.3 for infliximab (0-45.8) and 4.6 for controls (CI, 4.3-5.0). No cases of HZ were seen among patients treated with alefacept, efalizumab or adalimumab. In a multivariate analysis, age, female sex, healthcare utilization pattern and corticosteroid treatment were associated with the time to HZ infection. The association of HZ with infliximab approached statistical significance (Hazard ratio: 1.77, 95% CI: 0.92-3.43), but none of the other biologic drugs were significantly associated with the risk of HZ.

CONCLUSION

Among patients with psoriasis, treatment with some biologic drugs was associated with a higher incidence of HZ compared with controls, though the difference was not statistically significant.

Для цитирования: Dreiher J, Kresch F S, Comaneshter D, Cohen A D. Risk of Herpes zoster in patients with psoriasis treated with biologic drugs.. Journal of the European Academy of Dermatology and Venereology : JEADV. 2011. DOI: 10.1111/j.1468-3083.2011.04230.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.